Showing results (71-80 of 99) with videos related to

Sort By:
Pageof 10
Cancer Letters|July 22, 2018
The positive inotropic agent DPI-201106 selectively reverses ABCB1-mediated multidrug resistance in cancer cell linesSung-Han Hsiao, Megumi Murakami, Ni Yeh, et al.
BMC Women'S Health|October 10, 2022
Positive intervention effect of mobile health application based on mindfulness and social support theory on postpartum depression symptoms of puerperaeChao Liu, Hao Chen, Fang Zhou, et al.
Journal of Natural Products|April 30, 2020
Licochalcone A Selectively Resensitizes ABCG2-Overexpressing Multidrug-Resistant Cancer Cells to Chemotherapeutic DrugsChung-Pu Wu, Sabrina Lusvarghi, Sung-Han Hsiao, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 7, 2022
The multi-targeted tyrosine kinase inhibitor SKLB610 resensitizes ABCG2-overexpressing multidrug-resistant cancer cells to chemotherapeutic drugsChung-Pu Wu, Megumi Murakami, Yu-Shan Wu, et al.
International Journal of Molecular Sciences|November 11, 2022
Hydroxygenkwanin Improves the Efficacy of Cytotoxic Drugs in ABCG2-Overexpressing Multidrug-Resistant Cancer CellsYan-Qing Li, Megumi Murakami, Yang-Hui Huang, et al.
Environmental Science and Pollution Research International|June 12, 2024
Influence of gestational hypertension and maternal air pollutant exposure on birth outcomesTai-Ho Hung, Te-Yao Hsu, Jie Hsu, et al.
Biochemical Pharmacology|March 13, 2021
The third-generation EGFR inhibitor almonertinib (HS-10296) resensitizes ABCB1-overexpressing multidrug-resistant cancer cells to chemotherapeutic drugsChung-Pu Wu, Tai-Ho Hung, Sabrina Lusvarghi, et al.
Frontiers in Cell and Developmental Biology|August 5, 2021
Branebrutinib (BMS-986195), a Bruton's Tyrosine Kinase Inhibitor, Resensitizes P-Glycoprotein-Overexpressing Multidrug-Resistant Cancer Cells to Chemotherapeutic AgentsChung-Pu Wu, Megumi Murakami, Yu-Shan Wu, et al.
European Journal of Pharmacology|December 26, 2024
Vodobatinib overcomes cancer multidrug resistance by attenuating the drug efflux function of ABCB1 and ABCG2Yen-Ching Li, Bing-Huan Lin, Megumi Murakami, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 15, 2024
The colony-stimulating factor-1 receptor inhibitor edicotinib counteracts multidrug resistance in cancer cells by inhibiting ABCG2-mediated drug effluxYen-Ching Li, Yun-Chieh Lee, Megumi Murakami, et al.
Pageof 10